Data last refreshed 2 hours ago

Atlassian CorporationTEAM

NASDAQTechnology

NEUTRAL

$80.63

P/E

PEG

FCF Yield

Rev Growth YoY

+31.7% YoY

Gross Margin

84.9%

Health Score

7/10

D/E Ratio

0.92

Confidence

LOW


Business Snapshot

Atlassian provides collaboration and productivity software for enterprise teams, anchored by flagship products Jira, Confluence, and Trello. The company operates in the competitive software-as-a-service market and holds a strong position in Agile DevOps, IT service management, and team collaboration, competing with Microsoft and smaller vendors. Atlassian is a large-cap software company with TTM revenue of $6.19B, reflecting a subscription-heavy recurring revenue model. Its key differentiator is a broad ecosystem of integrated products that create high switching costs for customers, driving a loyal enterprise base.

Financial Health

Gross margin stands at 84.9%, nearly flat from 85.0% a year ago, indicating stable pricing and cost efficiency. Net margin is flagged as unreliable due to a data-source error and should not be used for analysis...

Risk Assessment

  • VALUATION — Price/Book of 44.92x is exceptionally high, signalling that the market prices the company far above its tangible book value, typical for SaaS but a risk if growth slows.
  • EARNINGS QUALITY — Despite positive revenue growth, TTM net income is negative at -$216.81M, indicating that operating leverage has not yet materialised.
  • 52-WEEK POSITION — At $80.63, the stock trades well below the midpoint of the 52-week range ($56.01–$230.63), suggesting persistent selling pressure and a 65% decline from the high.
  • TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
  • PROFITABILITY UNCERTAINTY — The net margin figure is flagged as unreliable due to a data-source error, leaving the true profitability picture unclear....
Last updated 2 hours ago · Data sourced from FMP & Finnhub · Not financial advice